nach oben

Erschienen in:

01.12.2012 | Policy Papers

The Medical Expenditure Panel Survey (MEPS) Experiences with Cancer Survivorship Supplement

verfasst von: K. Robin Yabroff, Emily Dowling, Juan Rodriguez, Donatus U. Ekwueme, Helen Meissner, Anita Soni, Catherine Lerro, Gordon Willis, Laura P. Forsythe, Laurel Borowski, Katherine S. Virgo

Erschienen in: Journal of Cancer Survivorship | Ausgabe 4/2012

Einloggen, um Zugang zu erhalten

Abstract

Introduction

The prevalence of cancer survivorship in the USA is expected to increase in the future because the US population is increasing in size and is aging and because survival following diagnosis is improving for many types of cancer. Medical care costs associated with cancer are also projected to increase dramatically. However, currently available data for estimating medical care costs and other important aspects of the burden of cancer, including time spent receiving medical care, productivity loss due to morbidity for patients and their families, and financial hardship, are limited, particularly in the population under the age of 65.

Methods

We describe selected publicly available data sources for estimating the burden of cancer in the USA and a new collaborative effort to improve the quality of these data: the nationally representative Medical Expenditure Panel Survey (MEPS) Experiences with Cancer Survivorship Supplement.

Conclusions

Data from this effort can be used to address key gaps in cancer survivorship research related to medical care costs, employment patterns, financial hardship, and other aspects of the burden of illness for cancer survivors and their families.

Implications for cancer survivors

Research using the MEPS Experiences with Cancer Survivorship Supplement can inform efforts by health care policy makers, healthcare systems, providers, and employers to improve the cancer survivorship experience in the USA.

Howlander N, Noone AM, Krapcho M, Neyman N, Aminou R, Waldron W, et al. SEER cancer statistics review, 1975-2008. Bethesda: National Cancer Institute; 2011.

Kohler BA, Ward E, McCarthy BJ, Schymura MJ, Ries LAG, Eheman C, et al. Annual report to the nation on the status of cancer, 1975–2007, featuring tumors of the brain and other nervous system. J Natl Cancer Inst. 2011;103:714–36.PubMedCrossRef

Mariotto AB, Yabroff KR, Shao Y, Feuer EJ, Brown ML. Projections of the cost of cancer care in the United States: 2010–2020. J Natl Cancer Inst. 2011;103(2):117–28.PubMedCrossRef

Berry DA, Cronin KA, Plevritis SK, Fryback DG, Clarke L, Zelen M, et al. Effect of screening and adjuvant therapy on mortality from breast cancer. N Engl J Med. 2005;353:1784–92.PubMedCrossRef

Dowling E, Yabroff KR, Mariotto AB, McNeel T, Zeruto C, Buckman D. Burden of illness in adult survivors of childhood cancers: findings from a population-based national sample. Cancer. 2010;116(15):3712–21.PubMedCrossRef

Yabroff KR, Lawrence WF, Clauser S, Davis WW, Brown ML. Burden of illness in cancer survivors: findings from a population-based national sample. J Natl Cancer Inst. 2004;96:1322–30.PubMedCrossRef

Weaver KE, Rowland JH, Bellizzi KM, Aziz NM. Forgoing medical care because of cost: assessing disparities in healthcare access among cancer survivors living in the United States. Cancer. 2010;116(14):3493–504.PubMedCrossRef

Schwartz K, Claxton G, Martin K, Schmidt C. Spending to survive: cancer patients confront holes in the health insurance system. Kaiser Family Foundation and American Cancer Society; 2009.

Hewitt M, Greenfield S, Stovall E. From cancer patient to cancer survivor: lost in translation. Washington, DC: National Academies Press; 2006.

10.

U.S. Department of Health & Human Services. Affordable Care Act. 2011. http://www.healthcare.gov/. Accessed 4 November 2011.

11.

Lund JL, Yabroff KR, Ibuka Y, Russell LB, Barnett PG, Lipscomb J, et al. Inventory of data sources for estimating health care costs in the United States. Med Care. 2009;47(7 Suppl 1):S127–42.PubMedCrossRef

12.

Yabroff KR, Lund JL, Kepka D, Mariotto AB. Economic burden of cancer in the US: estimates, projections, future research. Cancer Epidemiol Biomarkers Prev. 2011;20(10):2006–14.PubMedCrossRef

13.

Agency for Healthcare Research and Quality. Healthcare Cost and Utilization Project (HCUP). 2010. http://www.ahrq.gov/data/hcup/. Accessed 4 January 2012.

14.

Seifeldin R, Hantsch JJ. The economic burden associated with colon cancer in the United States. Clin Ther. 1999;21:1370–9.PubMedCrossRef

15.

Newton AN, Ewer SR. Inpatient cancer treatment: an analysis of financial and nonfinancial performance measures by hospital-ownership type. J Health Care Finance. 2010;37(2):56–80.PubMed

16.

Warren JL, Klabunde CN, Schrag D, Bach PB, Riley GF. Overview of the SEER-Medicare data: content, research applications, and generalizabilty to the United States elderly population. Med Care. 2002;40(8 Suppl):IV-3–IV-18.

17.

Hackbarth GM. Medicare Cost-sharing and Supplemental Insurance. Statement before the Subcommittee on Health, Committee on Ways and Means, U.S. House of Representatives. 2003.

18.

Crystal S, Johnson RW, Harman J, Sambamoorthi U, Kumar R. Out-of-pocket health care costs among older Americans. J Gerontol B Psychol Sci Soc Sci. 2000;55:S51–62.PubMedCrossRef

19.

Yabroff KR, Lamont EB, Mariotto A, Warren JL, Topor M, Meekins A, et al. Cost of care for elderly cancer patients in the United States. J Natl Cancer Inst. 2008;100(9):630–41.PubMedCrossRef

20.

Warren JL, Yabroff KR, Meekins A, Topor M, Lamont EB, Brown ML. Evaluation of trends in the cost of initial cancer treatment. J Natl Cancer Inst. 2008;100:888–97.PubMedCrossRef

21.

Yabroff KR, Davis WW, Lamont EB, Fahey A, Topor M, Brown ML, et al. Patient time costs associated with cancer care. J Natl Cancer Inst. 2007;99:14–23.PubMedCrossRef

22.

Centers for Disease Control and Prevention. National Health Interview Survey. 2011. http://www.cdc.gov/nchs/nhis.htm. Accessed 4 January 2012.

23.

Hewitt M, Rowland JH, Yancik R. Cancer survivors in the United States: age, health, and disability. J Gerontol A Biol Sci Med Sci. 2003;58:82–91.PubMedCrossRef

24.

Sabatino SA, Coates RJ, Uhler RJ, Alley LG, Pollack LA. Health insurance coverage and cost barriers to needed medical care among US adult cancer survivors age <65 years. Cancer. 2006;106(11):2466–75.PubMedCrossRef

25.

Cohen JW, Cohen SB, Banthin JS. The medical expenditure panel survey: a national information resource to support healthcare cost research and inform policy and practice. Med Care. 2009;47(7 Suppl 1):S44–50.PubMedCrossRef

26.

Short PF, Moran JR, Rajeshwari P. Medical expenditures of adult cancer survivors aged <65 years in the United States. Cancer. 2011;117(12):2791–800.PubMedCrossRef

27.

Howard DH, Molinari N-A, Thorpe KE. National estimates of medical costs incurred by nonelderly cancer patients. Cancer. 2004;100:883–91.PubMedCrossRef

28.

Thorpe KE, Howard D. Health insurance and spending among cancer patients. Health Aff (Millwood). 2003 Apr 9;(Suppl Web Exclusives):W3-189; 198.

29.

Tangka FK, Trogdon JG, Richardson LC, Howard D, Sabatino SA, Finkelstein EA. Cancer treatment cost in the United States. Cancer. 2010;116(14):3477–84.PubMedCrossRef

30.

Finkelstein EA, Tangka FK, Trogdon JG, Sabatino SA, Richardson LC. The personal financial burden of cancer for the working age population. Am J Manag Care. 2009;15(11):801–6.PubMed

31.

National Cancer Institute. Medical Expenditure Panel Survey (MEPS): Experiences with Cancer Survivorship Supplement. 2011. http://healthservices.cancer.gov/surveys/meps/. Accessed 4 January 2012.

32.

Lerro CC, Stein KD, Smith T, Virgo KS. A systematic review of large-scale surveys of cancer survivors conducted in North America, 1990–2011, under review. 2011.

33.

Willis G. Cognitive interviewing: a tool for improving questionnaire design. Thousand Oaks: Sage; 2005.

34.

Tourangeau R, Rips LJ, Rasinski K. The psychology of survey response. Cambridge: Cambridge University Press; 2000.

35.

DeNavas-Walt C, Proctor BD, Smith JC. Income, Poverty, and Health Insurance Coverage in the United States: 2008. 2009. http://www.census.gov/prod/2009pubs/p60-236.pdf. Accessed 4 January 2012.

36.

Smith TJ, Penberthy L, Desch CE, et al. Differences in initial treatment patterns and outcomes of lung cancer in the elderly. Lung Cancer. 1995;13:235–52.PubMedCrossRef

37.

Farrow DC, Hunt WC, Samet JM. Geographic variation in the treatment of localized breast cancer. N Engl J Med. 1992;326:1097–101.PubMedCrossRef

38.

Satariano ER, Swanson GM, Moll PP. Nonclinical factors associated with surgery received for early stage breast cancer. Am J Public Health. 1992;82:195–8.PubMedCrossRef

39.

Yabroff KR, Warren JL, Banthin J, Schrag D, Mariotto A, Lawrence W, et al. Comparison of approaches for estimating prevalence costs of care for cancer patients: what is the impact of data source? Med Care. 2009;47(7 Suppl 1):S64–9.PubMedCrossRef

40.

Yabroff KR, Warren JL, Schrag D, Meekins A, Topor M, Brown ML. Comparison of approaches for estimating incidence costs of care for colorectal cancer patients. Med Care. 2009;47(7 Suppl 1):S56–63.PubMedCrossRef

Titel: The Medical Expenditure Panel Survey (MEPS) Experiences with Cancer Survivorship Supplement
verfasst von: K. Robin Yabroff
Emily Dowling
Juan Rodriguez
Donatus U. Ekwueme
Helen Meissner
Anita Soni
Catherine Lerro
Gordon Willis
Laura P. Forsythe
Laurel Borowski
Katherine S. Virgo
Publikationsdatum: 01.12.2012
Verlag: Springer US
Erschienen in: Journal of Cancer Survivorship / Ausgabe 4/2012
Print ISSN: 1932-2259
Elektronische ISSN: 1932-2267
DOI: https://doi.org/10.1007/s11764-012-0221-2

Neu im Fachgebiet Onkologie

24.04.2024 | DGIM 2024 | Nachrichten

Springer Medizin

The Medical Expenditure Panel Survey (MEPS) Experiences with Cancer Survivorship Supplement

Abstract

Introduction

Methods

Conclusions

Implications for cancer survivors

Neu im Fachgebiet Onkologie

Bei Senioren mit Prostatakarzinom auf Anämie achten!

ICI-Therapie in der Schwangerschaft wird gut toleriert

Krebspatienten impfen: Was? Wen? Und wann nicht?

Müde im Alter? Auch an die Nebenniere denken

Update Onkologie

Springer Medizin

Abstract

Introduction

Methods

Conclusions

Implications for cancer survivors

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 4/2012

Differences in self-assessed health by socioeconomic group amongst people with and without a history of cancer: an analysis using representative data from Scotland

Association of bone mineral density with incidental renal stone in long-term survivors of childhood acute lymphoblastic leukemia

Prevalence and prognostic effect of sarcopenia in breast cancer survivors: the HEAL Study

Marriage and divorce among young adult cancer survivors

Ethnic disparities in colonoscopy use among colorectal cancer survivors: a systematic review

Sources of uncertainty in cancer survivorship

Neu im Fachgebiet Onkologie

Bei Senioren mit Prostatakarzinom auf Anämie achten!

ICI-Therapie in der Schwangerschaft wird gut toleriert

Krebspatienten impfen: Was? Wen? Und wann nicht?

Müde im Alter? Auch an die Nebenniere denken

Update Onkologie